KT&G Overview

  • Founded
  • 1987
Founded
  • Status
  • Public
  • Employees
  • 4,435
Employees
  • Stock Symbol
  • 033780
Stock Symbol
  • Investments
  • 3
  • Share Price
  • $68.94
  • (As of Friday Closing)

KT&G General Information

Description

KT&G primarily manufactures and sells tobacco products in South Korea. Its flagship cigarette brand is Esse. Other brands include This, The One, Bohem, and Raison. More than two thirds of the company's revenue come from tobacco sales in South Korea. Tobacco sales outside of South Korea generate another fourth of the company's total revenue and are primarily generated in the Middle East and Asia, although the company sells its product in roughly 50 countries spanning the globe. The remaining company sales are from KT&G's businesses that invest in real estate and sell ginseng products, cosmetics, and pharmaceuticals.

Contact Information

Website
www.ktng.com
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Other Consumer Non-Durables
Stock Exchange
KRX
Primary Office
  • Beotkkot Street 71
  • Daedeog-gu
  • Daejeon, 306-712
  • South Korea
+82 000-000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

KT&G Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$68.94 $69.65 $68.03 - $81.13 $8.55B 124M 370K $7.83

KT&G Financials Summary

In Thousands,
USD 		TTM 30-Jun-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 7,547,959 7,281,938 8,258,867 9,336,318
Revenue 4,763,014 4,490,247 4,256,338 4,068,301
EBITDA 1,512,926 1,526,026 1,396,178 1,331,854
Net Income 974,892 992,410 887,597 824,621
Total Assets 10,027,573 10,512,585 9,282,549 9,119,038
Total Debt 138,008 141,180 143,834 204,237
Public Fundamental Data provided by Morningstar, Inc. disclaimer

KT&G Executive Team (2)

Name Title Board Seat Contact Info
Bok-In Baek Chief Executive Officer & President & Executive Director
Tae Kim U.S. Mergers & Acquisitions Team Leader
To view KT&G’s complete executive team members history, request access »

KT&G Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

KT&G Investments & Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00&0 0000 00000000 27-Dec-2011 000000000000000000 000.00 Drug Discovery 000-00 0000
0000000000 01-Mar-2006 00000 00000 00 Pharmaceuticals
Yungjin Pharmaceutical 01-Jan-2004 Merger/Acquisition Pharmaceuticals
To view KT&G’s complete investments and acquisitions history, request access »

Ready to get started?

Request a free trial

KT&G Subsidiaries (1)

Company Name Industry Location Founded
0000000 0000000000 Pharmaceuticals Seoul, South Korea 0000
To view KT&G’s complete subsidiaries history, request access »

KT&G Exits (2)

Company Name Exit Date Exit Type Exit Size Status Buyers
00&0 0000 00000000 27-Dec-2011 000000000000000000 000.00 Completed
  • 00&0
Genematrix 01-Mar-2006 Later Stage VC Completed
To view KT&G’s complete exits history, request access »